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http://dx.doi.org/10.1016/j.stemcr.2016.08.008SUMMARYWnt signaling is a key regulator of vertebrate heart development; however, specific roles for human cardiomyocyte development remain
uncertain. Herewe use human embryonic stem cells (hESCs) to analyze systematically in human cardiomyocyte development the expres-
sion of endogenousWnt signaling components,monitor pathway activity, anddissect stage-specific requirements for canonical andnon-
canonical Wnt signaling mechanisms using small-molecule inhibitors. Our analysis suggests that WNT3 and WNT8A, via FZD7 and
canonical signaling, regulate BRACHYURYexpression andmesoderm induction; thatWNT5A/5B, via ROR2 and noncanonical signaling,
regulateMESP1 expressionandcardiovascular development; and that later indevelopmentWNT2,WNT5A/5B, andWNT11, via FZD4and
FZD6, regulate functional cardiomyocyte differentiation via noncanonical Wnt signaling. Our findings confirm in human development
previously proposed roles for canonicalWnt signaling in sequential stages of vertebrate cardiomyogenesis, and identifymore precise roles
for noncanonical signaling and for individual Wnt signal and Wnt receptor genes in human cardiomyocyte development.INTRODUCTION
The human heart develops as the first functional organ in
the embryo. In the lateral plate mesoderm (LPM) cardiac
progenitor cells are induced, which can subsequently
differentiate into heart muscle cells (cardiomyocytes)
(Rosenthal and Harvey, 2010; Sylva et al., 2014). Wnt
signaling, a well-known key regulator of vertebrate
cardiomyocyte differentiation (Hoppler et al., 2014), acts
through several molecular mechanisms (Hoppler and Na-
kamura, 2014): a b-catenin-dependent, so-called canonical
pathway, and b-catenin-independent, so-called noncanon-
ical pathways, among which a JNK-dependent pathway is
prominent during heart development (Gessert and Ku¨hl,
2010; Gessert et al., 2008; Pandur et al., 2002a, 2002b).
Several studies in mouse and other experimental models
have described diverse, and often opposing, effects of ca-
nonical and noncanonical Wnt signaling on subsequent
cardiomyocyte differentiation, leading to the argument
that particularly the JNK-mediated noncanonical pathway
may function in this context to antagonize canonical
Wnt signaling (Abdul-Ghani et al., 2011; Cohen et al.,
2012; reviewed by Hoppler et al., 2014). In addition, ca-
nonical Wnt signaling has been shown to play multiple
and conflicting roles at different stages of heart develop-
ment (Gessert and Ku¨hl, 2010; Naito et al., 2006).
However, specific roles for Wnt signaling in human
cardiomyocyte development remain unclear, particularly
regarding which endogenous Wnt ligands and Wnt recep-
tors are involved.764 Stem Cell Reports j Vol. 7 j 764–776 j October 11, 2016 j ª 2016 The A
This is an open access article under the CC BY license (http://creativecommoIn this study we therefore used human embryonic stem
cells (hESCs) to dissect stage-specific requirements of Wnt
signaling and to identify endogenous Wnt ligand and re-
ceptor genes directing human embryonic cardiomyocyte
development.RESULTS
Investigating Wnt Signaling during Human
Cardiomyocyte Development Using hESCs
To study sequential stages of human cardiomyocyte devel-
opment in vitro, we explored established hESC differenti-
ation protocols. With two hESC cell lines (H9 and H7)
we used an activin/bone morphogenetic protein (BMP)-
based protocol, hereby named the AB + WNTi protocol
(Figure 1A and Experimental Procedures, modified from
Mendjan et al., 2014), and a CHIR99021-based protocol,
hereby named C + WNTi (Figure 1B and Experimental
Procedures, modified from Lian et al., 2013). As previously
shown, these protocols lead to loss of pluripotency, induc-
tion of mesoderm identity, development of cardiac pre-
cursor identity in an LPM context, and differentiation
into beating primary cardiomyocytes (Figures S1C–S1F).
These protocols are thereby clearly following the normal
developmental progress in the embryonic heart (Rosen-
thal and Harvey, 2010; Sylva et al., 2014). Beating
activity is observed as early as day 6 for the AB + WNTi
protocol (Movie S1) and day 9 for the C + WNTi protocol
(Movie S2).uthor(s).
ns.org/licenses/by/4.0/).
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Consistent with findings frommodel systems (e.g., Singh
et al., 2007; Ueno et al., 2007), inhibition of canonicalWnt
signaling following mesoderm induction is essential for
efficient subsequent human cardiomyocyte differentiation
(Figures S1A and S1B) (see also Burridge et al., 2014; Cao
et al., 2013; Laflamme et al., 2007; Lian et al., 2012; Mend-
jan et al., 2014; Paige et al., 2010; Willems et al., 2011). In
this study wemainly use the small-moleculeWnt inhibitor
IWP2 (an inhibitor ofWnt ligand secretion which, as such,
interferes with any Wnt-mediated signaling, irrespec-
tive of pathway mechanisms) and also IWR1 (a specific
inhibitor of canonical Wnt/b-catenin signaling) (Chen
et al., 2009). Either inhibitor promotes subsequent cardio-
myocyte differentiation, confirming that inhibition of
canonical Wnt signaling is sufficient in this context for
differentiation of hESCs into functional cardiomyocytes
(Figure S1).
Endogenous Expression ofWnt Signaling Ligands and
Receptors Suggests Stage-Specific Roles for Wnt
Signaling in Cardiomyocyte Differentiation
Manipulation of Wnt signaling is a well-established exper-
imental tool for driving cardiomyocyte differentiation in
hESC protocols (e.g., Lian et al., 2012), suggesting a key
role for Wnt pathways in endogenous cardiomyocyte
development. So far, information about specific Wnt sig-
nals and receptors is only available from animal models
(Table S1; Eisenberg and Eisenberg, 1999; Hardy et al.,
2008; Kilian et al., 2003; Lavery et al., 2008; Pandur et al.,
2002a; Ulrich et al., 2005). To identify WNT signals and re-
ceptors that may regulate cardiomyocyte development in
humans, we systematically studied the expression of all
19 genes encodingWNT signals (Figure S2A), of all ten friz-
zled (FZD) receptors, and ofWNTco-receptors at key stages
of human cardiomyocyte development (Figure S2B), using
the aforementioned protocols.Figure 1. WNT Signal and Receptor Gene Expression in Human Car
(A) Schematic description of the cardiomyocyte differentiation protoc
through mesoderm (M) induction with reagents including activin A
ultimately cardiomyocyte (CM) development with reagents including
(B) Schematic description of the cardiomyocyte differentiation protoc
adding the Wnt signaling agonist CHIR99021, C, and then promotes ca
IWP2).
(C) WNT gene expression in human cardiomyocyte differentiation prot
5A, and 5B early during mesoderm induction and expression of WNT5
(D) FZD receptor gene and WNT co-receptor gene expression in human
prominent expression of FZD7 and ROR2 early during mesoderm induc
(E) Schematic representation of the working hypothesis about Wnt sig
early during mesoderm induction and later during cardiomyocyte diff
qPCR data are presented as means ± SEM for n = 3 independent exper
Procedures for further details of cardiomyocyte differentiation protoc
genes, all FZD genes, and several WNT co-receptor genes, and Table S
766 Stem Cell Reports j Vol. 7 j 764–776 j October 11, 2016We discovered that WNT3 and WNT5A are particularly
highly expressed during mesoderm induction, together
withWNT8A andWNT5B. Much later in development, dur-
ing cardiomyocyte differentiation, high expression of
WNT2,WNT5A,WNT5B, andWNT11wasobserved (Figures
1C and S2A). We also uncovered strong expression of both
FZD7 and ROR2 during mesoderm induction, and FZD4
and FZD6 expression during cardiomyocyte differentiation
(Figures 1D and S2B).WNT3 andWNT8A are known to acti-
vate the canonical Wnt pathway (Yamaguchi, 2008) while
WNT5A, WNT5B, and WNT11 are often associated with
noncanonical Wnt signaling mechanisms (Cohen et al.,
2012;Heetal., 1997; Panduret al., 2002a;Yamaguchi, 2008).
These results allowed us to formulate an initial working
hypothesis (Figure 1E) proposing that canonical Wnt
signaling is activated during mesoderm induction by
WNT3 andWNT8A, via FZD7; and that JNK-mediated non-
canonical Wnt signaling is activated by WNT5A and
WNT5B, probably involving ROR2. During cardiomyocyte
differentiation stages, the expression of WNT5A, WNT5B,
andWNT11 suggests that these ligands activate noncanon-
ical Wnt signaling via FZD4 and FZD6, and possibly
together withWNT2, presumably through a JNK-mediated
mechanism as previously suggested in the mouse system
(Gessert and Ku¨hl, 2010; Pandur et al., 2002a). These pro-
posed functions of human genes in this working hypothe-
sis are on the whole consistent with the expression of
the mouse homologs, where such information is available
(Table S1). However, we proceeded to test further predic-
tions of this working hypothesis.
Canonical and Noncanonical Wnt Pathway
Activation during Different Stages of Human
Cardiomyocyte Differentiation
To test our working hypothesis (Figure 1E) and further
explore this model, we studied Wnt signaling pathwaydiomyocyte Development Using hESC Differentiation Protocols
ol AB + WNTi. This established protocol guides pluripotent hESC first
and BMP4, AB, and then drives lateral plate mesoderm (LPM) and
Wnt inhibitors, WNTi (IWR1 or IWP2).
ol C + WNTi. This established protocol drives mesoderm induction by
rdiomyocyte development with Wnt signaling inhibitors, WNTi (i.e.,
ocols by qPCR analysis. Note the prominent expression of WNT3, 8A,
A, 5B, 2, and 11 later during cardiomyocyte differentiation.
cardiomyocyte differentiation protocols analyzed by qPCR. Note the
tion and FZD4 and FZD6 later during cardiomyocyte differentiation.
naling mechanisms regulating human cardiomyocyte development
erentiation.
iments. GAPDH was used as a housekeeping gene. See Experimental
ols. See Figure S2 for comprehensive expression analysis of all WNT
1 for information on spatial expression of mouse homologs.
A B
C D
E F
(legend on next page)
Stem Cell Reports j Vol. 7 j 764–776 j October 11, 2016 767
activity during sequential stages of the cardiomyocyte dif-
ferentiation protocols.
Canonical Wnt signaling activity was monitored by
following the expression levels of the known Wnt/b-cate-
nin target gene AXIN2 (Yan et al., 2001) and by analyzing
protein abundance and localization of active b-catenin
(ABC) (Staal et al., 2002). Our molecular understanding of
noncanonical WNT signaling is still rudimentary, and
methods for monitoring noncanonical Wnt signaling ac-
tivity are therefore less well established; specifically, there
is no reliable pathway indicator gene for noncanonical
WNT signaling. Since a JNK-dependent Wnt pathway is
prominent during heart development (Gessert and Ku¨hl,
2010; Hoppler et al., 2014), we monitored expression of
the recently identified target gene of noncanonical Wnt/
JNK signaling, ALCAM (Choudhry and Trede, 2013; Cizel-
sky et al., 2014), and protein abundance and cellular local-
ization of phosphorylated JNK (Pandur et al., 2002a).
As predicted by the working hypothesis (Figure 1E), we
find that AXIN2 expression is high during mesoderm in-
duction (Figure 2A), and consistently the ABC protein is
enriched (Figure 2C) and has a nuclear localization in
induced mesoderm (Figure 2E), demonstrating active ca-
nonicalWnt signaling during these early stages. Contrarily,
AXIN2 expression levels clearly reveal that canonical Wnt
signaling is reduced after mesoderm induction in these hu-
man cardiomyocyte differentiation protocols, and remains
reduced during cardiomyocyte differentiation (Figure 2A).
These findings are further supported by the low levels of
ABC protein at these later stages (Figures 2C and 2E).
Consistent with the working hypothesis (Figure 1E), we
find activation of JNK-mediated signaling during meso-
derm induction when analyzing phosphorylated JNK pro-
tein levels and cellular localization (Figures 2D and 2F),
and ALCAM expression gradually increasing at later stagesFigure 2. Activity of Wnt Signaling Pathways in Human Cardiomy
(A) Gene expression (analyzed by qPCR) of the canonical Wnt target g
and reduced expression during cardiomyocyte differentiation.
(B) Gene expression (analyzed by qPCR) of the proposed noncanonica
later stages of the protocol, but decreasing following addition of Wn
(C) Top panel: western blot analysis of active b-catenin (ABC) and b
quantified western analysis showing protein abundance of ABC relati
dance confined to mesoderm induction.
(D) Top panel: western blot analysis of phosphorylated JNK (pJNK) and
IWP2) protocols. Bottom panel: quantified western analysis showing
PCNA. Note increased pJNK abundance mostly confined to mesoderm
(E) Tissue-wide analysis of Wnt/b-catenin pathway activity. Immun
stages of cardiomyocyte differentiation protocols, marked by the loca
(LPM), and MYH6 (cardiomyocytes). Note uniform nuclear localization
(F) Tissue-wide analysis of Wnt/JNK pathway activity. Immunocytoche
cardiomyocyte differentiation protocols, marked by the localization o
MYH6 (cardiomyocytes). Note uniform cytoplasmic pJNK localization
qPCR data are presented as means ± SEM normalized to day 0 for n = 3
768 Stem Cell Reports j Vol. 7 j 764–776 j October 11, 2016(Figure 2B). However, ALCAM is not expressed during
mesoderm induction andmight therefore not be a good in-
dicator of noncanonicalWnt/JNK signaling at this stage. At
later stages analysis of phosphorylated JNK did not consis-
tently indicate an increase, which would be contrary to the
prediction of the working hypothesis and the ALCAM
expression data. However, as expected, addition of IWP2
reduces ALCAM expression and JNK phosphorylation.
Altogether, these data support our working hypothesis
(Figure 1E), as far as showing that canonical Wnt signaling
is confined to mesoderm induction, and suggest potential
noncanonical Wnt signaling activity during mesoderm in-
duction and cardiomyocyte differentiation. We therefore
proceeded to further test our working hypothesis by exper-
imentally interfering with the Wnt pathway at critical
stages of cardiomyocyte development.
Both b-Catenin- and JNK-Mediated Signaling Are
Required Early during Mesoderm Development
To investigate any requirement for canonical and nonca-
nonical Wnt signaling during mesoderm induction, we
manipulated the AB + WNTi protocol by adding at this
stage the small molecules IWP2, IWR1, or JNKi (Figure 3A).
IWP2 is used as above to interfere with Wnt signaling
in general, and IWR1 as a specific inhibitor of canonical
Wnt/b-catenin signaling (Chen et al., 2009). JNKi
(SP600125) is used to inhibit JNK-dependent noncanonical
Wnt signaling (Pandur et al., 2002a).
Mesoderm induction is characterized by a dramatic
change of cell morphology, from round and small hESCs
tightly organized in colonies, to fibroblastoid mesodermal
cells that are well spread out from the original colony.
Experimental inhibition of either Wnt pathway clearly
interfered with these morphological rearrangements (Fig-
ure 3B) and, therefore, mesoderm induction.ocyte Differentiation Protocols
ene AXIN2. Note AXIN2 expression confined to mesoderm induction
l Wnt target gene ALCAM. Note ALCAM expression only increasing at
t inhibitor.
-actin in the AB /+ WNTi (i.e., IWP2) protocols. Bottom panel:
ve to the housekeeping protein b-actin. Note increased ABC abun-
proliferating cell nuclear antigen (PCNA) in the AB/+ WNTi (i.e.,
protein abundance of pJNK relative to the housekeeping protein
induction.
ocytochemistry analysis of activated b-catenin (ABC) at different
lization of OCT4 (pluripotent hESCs), BRY (T) (mesoderm), NKX2.5
of ABC confined to mesoderm induction stages. Scale bar, 50 mm.
mistry analysis of phosphorylated JNK (pJNK) at different stages of
f OCT4 (pluripotent hESCs), BRY (T) (mesoderm), NKX2.5 (LPM), and
early during mesoderm induction. Scale bar, 50 mm.
independent experiments. GAPDH was used as a housekeeping gene.
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Expression of the mesodermal markers BRACHYURY
(BRY [T]) and MIXL1 is found to be reduced following
inhibition of canonical Wnt signaling in the AB +
WNTi protocol, but only the expression of the earliest
cardiogenic marker MESP1 (David et al., 2008) is
decreased following inhibition of noncanonical WNT/
JNK signaling (Figure 3C). These effects on mesoderm for-
mation lead to expected consequences later, particularly
reduced levels of expression of the cardiac markers
cTNT, MYH6, and HCN4 (Figure 3D). These data suggest
that both branches of Wnt signaling are required during
initial mesodermal commitment; however, canonical and
noncanonical Wnt signaling play different roles at this
early stage.
To study any sufficiency for canonical WNT signaling in
this context, we used the C +WNTi protocol. Experimental
activation of canonical Wnt signaling (Figure 3E) with
CHIR99021 leads to expression of BRY (T) andMSX1 (start-
ing on experimental day 1) and more delayed MESP1
(experimental day 2) (Figure 3F). Conversely, absence of
exogenous Wnt activation results in lack of mesodermal
differentiation. More detailed analysis of Wnt signaling ac-
tivity at these stages shows that the Wnt/b-catenin
pathway is active earlier than the JNK-dependent pathway
(experimental day 1 and day 2, respectively) (Figure 3G),
which is also supported by AXIN2 and WNT3 expression
(associated with canonicalWnt signaling, Figure 3H) being
earlier than WNT5A and WNT5B (associated with nonca-Figure 3. Wnt Signaling Function during Mesoderm Development
(A) Schematic description of the cardiomyocyte differentiation prot
during mesoderm development. The protocol AB + WNTi (as in Figure 1
IWP2, IWR1, or JNKi [SP600125]) during mesoderm induction.
(B) Morphology of cultured cells (bright-field micrographs; scale bar, 4
and after 1 day (day 1, panels Bii–Bv) under different experimental
inhibition); (Biii) represents cells treated with JNKi; (Biv) represents
(C) Gene expression (qPCR analysis, relative to control) of markers of
(A). Note that JNK signaling appears to be specifically required for M
(D) Gene expression (qPCR analysis, relative to control) of cardiomyo
(E) Schematic description of the protocol to study sufficiency in thi
opment (as in Figure 1B).
(F) Gene expression of mesoderm markers (qPCR analysis) on day 0, d
MESP1 expression is induced later than BRY (T) and MSX1.
(G) Activity of Wnt signaling mechanisms during mesoderm developm
shown in (E). Immunocytochemistry of activated b-catenin (ABC) an
already on day 1, but noncanonical pathway activity mainly on day 2
(H) qPCR analysis showing expression of the canonical Wnt target gen
Wnt activation (CHIR99021) as shown in (E).
(I) qPCR analysis showing expression of WNT5A and 5B mainly on day
activation (CHIR99021) as shown in (E).
qPCR data are presented as means ± SEM for n = 3 independent experim
statistically significant difference between experimental and control
and two-way ANOVA for (F).
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
770 Stem Cell Reports j Vol. 7 j 764–776 j October 11, 2016nonical Wnt signaling, Figure 3I). Together, these results
show sequential activation and confirm different roles for
canonical and noncanonicalWNTsignaling during human
mesoderm induction.
Canonical and Noncanonical Wnt Signaling Have
Different Roles in Late Stages of Cardiomyocyte
Differentiation
Hardly anything is currently known about canonical and
noncanonicalWnt signaling at later stages of human cardi-
omyocyte differentiation. We therefore studied molecular
differentiation of cardiomyocytes when inhibition of
Wnt signaling by IWP2was experimentally prolonged (Fig-
ure 4A), and found decreased expression of cardiomyocyte
differentiation markers (Figure 4B), suggesting that Wnt
signaling function is required at these stages for cardiomyo-
cyte differentiation.
We now wondered whether we could rescue cardiomyo-
cyte differentiation by experimentally reinstating b-cate-
nin or JNK pathway activity (Figure 4C). Activation of
b-catenin signaling boosted AXIN2 expression (Figure 4D),
as expected, but caused further decreased cardiomyocyte
differentiation marker expression (Figure 4E), confirming
that canonical Wnt signaling at these stages is incompat-
ible with cardiomyocyte differentiation. Activation of
JNK signaling boostedALCAM expression (Figure 4F), as ex-
pected, but unexpectedly did not rescue the loss of differen-
tiation induced by IWP2 (Figure 4G).ocol to study the requirement for Wnt signaling pathway function
A) is modified to inhibit Wnt signaling mechanisms (by addition of
00 mm) at the start of the differentiation protocol (day 0, panel Bi)
conditions as shown in (A). (Bii) represents the control (no WNT
cells treated with IWR1; (Bv) represents cells treated with IWP2.
mesoderm induction at day 1.5 in different conditions as shown in
ESP1 expression.
cyte markers at day 9 in the different conditions shown in (A).
s context of Wnt signaling pathway function for mesoderm devel-
ay 1, and day 2 in the different conditions shown in (E). Note that
ent, in the presence of canonical Wnt activation (CHIR99021) as
d phosphorylated JNK (pJNK) suggests canonical pathway activity
during mesoderm development. Scale bar, 100 mm.
e AXIN2 and of WNT3 already on day 1, in the presence of canonical
2 during mesoderm development, in the presence of canonical Wnt
ents. GAPDH was used as a housekeeping gene. Asterisk indicates a
samples detected using one-way ANOVA (*p < 0.05) for (C) and (D)
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DISCUSSION
Vertebrate and invertebrate models have proved funda-
mental for gaining an understanding of animal heart devel-
opment and the signaling and transcriptional network
mechanisms governing this process. However, the molecu-
lar mechanisms underlying human heart development are
still largely unclear. hESCs offer unprecedented opportu-
nities to model and study human heart development
in vitro. However, so far most of the effort in the field has
been directed toward designing efficient protocols to differ-
entiate human cardiomyocytes in vitro. Interestingly, a
vast majority of these protocols relies on experimental
manipulation ofWnt signalingmechanisms (e.g., Bauwens
et al., 2011; Burridge et al., 2014; Chen et al., 2012; Elliott
et al., 2011; Gonzalez et al., 2011; Hemmi et al., 2014; Kar-
akikes et al., 2014; Kattman et al., 2011; Kempf et al., 2014;
Lian et al., 2012; Otsuji et al., 2014; Paige et al., 2010; Phil-
lips et al., 2008; Ting et al., 2014; Yang et al., 2008; Zhang
et al., 2015), suggesting important roles for WNT signaling
also in human heart development. However, while Wnt
signaling clearly represents a key regulator of vertebrate
heart development and particularly of cardiomyocyte dif-
ferentiation (reviewed by Hoppler et al., 2014), at present
there is no detailed understanding of the players and the
fundamental roles of Wnt signaling at sequential develop-
mental stages leading to human embryonic cardiomyocyte
differentiation. We therefore specifically set out to test
whether knowledge from animal model systems would be
confirmed for human cardiomyocyte development. Using
established hESC differentiation protocols, we studied theFigure 4. Wnt Signaling Function during Cardiomyocyte Different
(A) Schematic description of the protocol to study the requirement f
tiation. The protocol AB + WNTi (as in Figure 1A) is modified to extend
until day 7 (Late WNTi). AB + WNTi protocol is used as a control, as i
(B) Gene-expression analysis (qPCR) of cardiomyocyte markers with
cardiomyocyte marker gene expression with extended Wnt inhibition
(C) Schematic description of the protocol to study whether Wnt sig
b-catenin signaling (with CHIR99021, Late c/WNTr) or noncanonical
(D) Gene-expression analysis (qPCR) of the canonical Wnt target gen
CHIR99021.
(E) Gene-expression analysis (qPCR) of cardiomyocyte markers in the
Wnt/b-catenin signaling further reduces cardiomyocyte marker gene
(F) Gene-expression analysis (qPCR) of the proposed noncanonical Wn
strong induction of ALCAM expression by addition of anisomycin.
(G) Gene-expression analysis (qPCR) of cardiomyocyte markers in th
nonical Wnt/JNK signaling fails to rescue cardiomyocyte marker gene
(H) Schematic description of conclusions. Note that the function of
development can be separated temporally and in terms of marker gen
inhibitory, while noncanonical Wnt signaling is required for cardiomy
qPCR data are presented as means ± SEM for n = 3 independent experim
statistically significant difference between samples as indicated, whi
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
772 Stem Cell Reports j Vol. 7 j 764–776 j October 11, 2016activity and requirement of Wnt signaling pathways and
identified WNT signal and receptor genes during human
cardiomyocyte differentiation.
Evidence frommodel systems had previously suggested a
requirement for Wnt signaling during mesoderm induc-
tion. In fact, Brachyury is a known target of b-catenin-
mediatedWnt signaling (e.g., Arnold et al., 2000; Mendjan
et al., 2014; Yamaguchi et al., 1999; Zhang et al., 2013),
while WNT/JNK signaling had previously been associated
with morphogenesis at gastrulation (Hardy et al., 2008;
Tada et al., 2002; Tada and Kai, 2009). Here, we not only
confirm that similarly hESCs can only efficiently differen-
tiate in vitro into mesoderm when Wnt signaling is active,
but also show that canonical Wnt signaling acts before
noncanonical Wnt signaling in humans (Figure 4H). Our
data suggest that WNT3 and WNT8A regulate BRY (T)
expression and mesoderm induction via the canonical
pathway, after which WNT5A and WNT5B activate JNK-
mediated pathway activity to regulate MESP1 expression,
thereby indicating a role for WNT/JNK signaling that
goes beyond regulatingmorphogenesis during gastrulation
in the intact embryo. Consistently, our results also show
expression of FZD7 and the noncanonical receptor ROR2
duringmesoderm induction. Interestingly FZD7 had previ-
ously been identified in pluripotent hESCs, where it plays a
role in canonical WNT3-mediated self-renewal (Fernandez
et al., 2014). Our results suggest that WNT3 and WNT8A
and the canonical pathway regulate mesoderm induction
via the FZD7 receptor (although additional roles for FZD7
in mediating noncanonical mechanisms cannot be ruled
out, e.g., Medina et al., 2000), while ROR2 mediatesiation
or Wnt signaling pathway function during cardiomyocyte differen-
the inhibition of Wnt signaling mechanisms (by addition of IWP2)
ndicated.
and without extended Wnt inhibition, as in (A). Note the reduced
.
naling requirement can be rescued by reinstating canonical Wnt/
Wnt/JNK signaling (with anisomycin, Late nc/WNTr).
e AXIN2. Note strong induction of AXIN2 expression by addition of
different conditions shown in (C). Note that reinstating canonical
expression.
t target gene ALCAM in the different conditions shown in (C). Note
e different conditions shown in (C). Note that reinstating nonca-
expression.
canonical and noncanonical Wnt signaling early during mesoderm
e induction. Further note that later canonical Wnt signaling is still
ocyte differentiation (see text for further details).
ents. GAPDH was used as a housekeeping gene. Asterisk indicates a
ch was detected using two-way ANOVA.
WNT5A/B role in the commitment of the earliest cardio-
genic mesoderm (i.e., MESP1-positive cells).
We further confirm in human cells that inhibition of
specifically canonical Wnt signaling following mesoderm
induction is both necessary and sufficient for subsequent
efficient cardiomyocyte differentiation (Figure 4H). Exper-
imental activation of noncanonicalWnt/JNK signaling has
been shown in a variety of experimental models to pro-
mote cardiac specification (Bisson et al., 2015; Eisenberg
and Eisenberg, 1999; Terami et al., 2004), which, it has
been argued, may function by antagonizing canonical
pathway activity (reviewed in Hoppler et al., 2014). How-
ever, we observe little activation of noncanonical Wnt/
JNK signaling following mesoderm induction and little ev-
idence of pathway-relevant Wnt ligand or Wnt receptor
gene expression, which suggests that noncanonical Wnt/
JNK signaling may not be required at this specific stage.
Consistently, we find that experimental inhibition of JNK
signaling alone at this stage does not affect differentiation
of mesodermal cells into LPM and subsequently into cardi-
omyocytes. The effects observed by others on cardiac spec-
ification after experimental activation of noncanonical
Wnt/JNK signaling may be related to the earlier function
of Wnt/JNK signaling we have discovered (see above).
Finally, until now nothing was known about the role
of Wnt signaling during differentiation from cardiac pre-
cursors into human cardiomyocytes. In animal model
systems, a prominent role of noncanonical Wnt/JNK
signaling at this stage has been suggested, while it is still
not clear whether canonical Wnt signaling may play
further roles following cardiac mesoderm induction for
subsequent cardiomyocyte differentiation (both reviewed
in Gessert and Ku¨hl, 2010). We observe sustained expres-
sion of presumably noncanonical WNT5A, WNT5B, and
WNT11 at this stage (Figure 4H), but also WNT2, which
was conventionally believed to activate b-catenin-medi-
ated signaling (Goss et al., 2009). When Wnt signaling
was inhibited at this late stage, cardiomyocyte differentia-
tionwas negatively affected. However, activation of canon-
icalWnt signaling at this stage was found to be detrimental
for terminal cardiomyocyte differentiation, suggesting a
role solely for noncanonical Wnt signaling during cardio-
myocyte differentiation. The involvement ofwnt2 in cardi-
omyocyte differentiation from ESCs mediated by nonca-
nonical Wnt signaling had previously been identified in
the mouse (Onizuka et al., 2012), which our results now
suggest are conserved in human development. Our results
further suggest that noncanonical signaling at this stage is
mediated by FZD4 (Abdul-Ghani et al., 2011; Descamps
et al., 2012) and FZD6 (Gray et al., 2011; Guo et al.,
2004) receptors. However, experimental activation of JNK
signaling alone proved insufficient for rescuing cardiomyo-
cyte differentiation. Therefore, future experiments will berequired to explore the role of other noncanonical Wnt
signaling pathways in late cardiomyocyte differentiation,
which may work together with or instead of the JNK-medi-
ated pathway. Given that Ca2+ is needed for proper cardiac
development and heart function, the Wnt/Ca2+ pathway
may represent a mediator of noncanonical Wnt signaling
in this context (Panakova et al., 2010).
Overall, our study demonstrates that canonical and non-
canonical Wnt pathway mechanisms have specific roles in
regulating human cardiomyocyte differentiation that go
beyond simple mutual antagonism. The established hESC
differentiation protocols we used clearly proved useful to
distinguish different phases of Wnt pathway activity and
requirement, as well as stage-specific Wnt signal and Wnt
receptor gene expression (Figure 4H). Future analysis may
be able to determine more precisely whether canonical
and noncanonical Wnt signaling mechanisms operate at
exactly the same stage and in exactly the same tissue, and
whether specificWnt ligands and receptorsmediate canon-
ical and others noncanonical pathway activation. Given
the outstanding impact of cardiovascular disease on
society, a more detailed understanding of the regulatory
mechanisms underlying human embryonic cardiac muscle
commitment and differentiation will provide fundamental
insights into the etiology of congenital heart defects, and
may also suggest innovative therapeutic applications in
the field of regenerative medicine.EXPERIMENTAL PROCEDURES
hESC Differentiation Protocols
AB + WNTi
hESCs (NSCBno.WA09 [H9] andWA07 [H7]) were grownon inacti-
vatedmouse embryonic fibroblasts, as previously described (Thom-
son et al., 1998). All experiments were repeated with both cell lines
with comparable results, but results presented here are fromH9 cul-
ture. Differentiation toward mesoderm, LPM, and beating cardio-
myocyteswas performed in chemically definedmediumcontaining
polyvinyl alcohol, essentially as previously described (Bernardo
et al., 2011; Mendjan et al., 2014) with only minor modifications
(Figure 1A): for the first 36 hr of the protocol cells were stimulated
with 20 ng/mL fibroblast growth factor 2 (FGF2),10 mM phosphoi-
nositide 3-kinase inhibitor (LY294002), 20 ng/mL activin A, and
10 ng/mL BMP4, for mesoderm induction; addition of 20 ng/mL
FGF2, 50ng/mLBMP4, 0.5mMretinoic acid, and5mMofWnt inhib-
itor (either IWR1or IWP2) fromday1.5 to day 5 allowed LPMdiffer-
entiation; finally, treatment with 5 ng/mL FGF2 and 10 ng/mL
BMP4 allowed differentiation into cardiomyocytes.
C + WNTi
hESCs (NSCB no. WA09 [H9] and WA07 [H7]) were grown on
mTeSR1/Matrigel Platform as per the manufacturer’s instructions.
All experiments were repeated with both cell lines with compa-
rable results, but results presented here are fromH7 culture. Differ-
entiation toward mesoderm, LPM, and beating cardiomyocytesStem Cell Reports j Vol. 7 j 764–776 j October 11, 2016 773
was performed essentially as previously described (Lian et al.,
2013) with only minor modifications (Figure 1B): for the first
48 hr of the protocol cells were stimulated with 12 mM
CHIR99021 in RPMI/low insulin-B27 for mesoderm induction;
subsequently, addition of the Wnt inhibitor IWP2 (5 mM) from
days 2 to 4 in RPMI/low insulin-B27 allowed LPM differentiation;
cells were then grown in RPMI/low insulin-B27 for a further 2 days;
finally, medium was changed to RPMI/B27 on day 6 and cells
were kept in culture until day 9 to allow differentiation into
cardiomyocytes.
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